The nuclear pharmacist works with a very specific group of drugs. These drugs generally exhibit no toxic effects and are used almost exclusively for diagnosis. In the past these have been the radioactive drugs used in nuclear medicine and the iodinated contrast agents used in radiology. However, with the advent of magnetic resonance imaging (MRI), there is an additional class of drugs used in radiology, the magnetopharmaceuticals. These drugs are designed especially for increasing diagnostic sensitivity with MRI. This article is intended to provide topical insight into the basics of MRI and magnetopharmaceuticals.
Get full access to this article
View all access options for this article.
References
1.
Bottomley PA : The basis of imaging and chemical analysis by NMR, in Partain CL (ed): Nuclear Magnetic Resonance and Correlative Imaging Modalities. New York, Society ofNuclear Medicine, 1984, pp 37-44
2.
Wehrli FW, Macfall JR, Prost JH: Impact of the choice of operating parameters on MR images, in Partain CL, Price RR, Patton JA, et al (eds): Magnetic Resonance Imaging (edition 2, vol 1). Philadelphia, Saunders, 1988, pp 73-86
3.
Ernst RR: A survey of MRI techniques, in Partain CL , Price RR, Patton JA, et al (eds): Magnetic Resonance Imaging (edition 2, vol 1). Philadelphia, Saunders, 1988, pp 21-42
4.
Tweedle MF, Brittain HG, Desreux JF, et al: Gadolinium complexes as NMR contrast agents. J Nucl Med27:915-916, 1986 (abstr)
5.
Burnett KR, Wolf GL, Shumacher RH Jr, et al: Gadolinium oxide: A prototype agent for contrast enhanced imaging of the liver and spleen with magnetic resonance. Magn Reson Imaging3:65-71, 1985
6.
Chilton HM, Jackals SC, Hinson WH, et al: Use of a paramagnetic substance, colloidal manganese sulfide, as an NMR contrast material in rats. J Nucl Med25:604-607, 1984
7.
Saini S., Stark DD, Hahn PF, et al: Ferrite particles: A superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology162:211-216, 1987
8.
Lauffer RB, Greif WL, Stark DD, et al: Iron-EHPG as an hepatobiliary NMR contrast agent: Initial imaging and biodistribution studies. J Comput Assist Tomogr9:431-438, 1985
9.
Engelstad BL , Ramos ED, Macapinlac HA, et al: Fe-HBED and Fe-EHPG:iron complexes exhibiting hepatobiliary enhancement in MRI. Clin Nucl Med11:19, 1986
10.
Worah D., Rocklage SM, Quay SC, et al: MR hepatobiliary imaging with a paramagnetic manganese chelate derived from pyridoxal-5-phosphate. Presented paper, Society of Magnetic Resonance in Medicine (work in progress), New York, August 1987, p 16
11.
Rzedzian RR , Pykett IL: Instant images of the human heart using a new, whole body MR imaging system. AJR149:245-250, 1987
12.
Wood ML: Thoracic and abdominal motion artifacts, in Stark DD, Bradley WG (eds): Magnetic Resonance Imaging. St Louis, Mosby, 1988, p 792
13.
Weinmann HJ , Brasch RC, Press WR et al: Characteristics of Gadolinium-DTPA complex: A potential NMR contrast agent. AJR142:619-624, 1984
14.
Runge VM, Stewart RG, Clanton JA, et al: Potential oral and intravenous paramagnetic NMR contrast agents . Radiology147:789-791, 1983 (Work in Progress).
15.
Brasch RC: (Work in Progress). Methods of contrast enhancement for NMR imaging and potential applications. Radiology147:781-788, 1983
16.
Runge VM, Clanton JA, Lukehart CM, et al: Paramagnetic agents for contrast-enhanced NMR imaging: A review . AJR141:1209-1215, 1983
17.
Tweedle MF, Brittain HG, Eckelman WC, et al: Principles of contrast-enhanced MRI, in Partain CL, Price RR, Patton JA, et al (eds): Magnetic Resonance Imaging (edition 2, vol 1). Philadelphia, Saunders, 1988, pp 793-809
18.
Whelan HT, Clanton JA, Moore PM, et al: Magnetic resonance brain tumor imaging in canine glioma. Neurology37:1235-1239, 1987
19.
Jackels SC, Kroos BR, Hinson WH, et al: Paramagnetic macrocyclic complexes as contrast agents for MR imaging: Proton nuclear relaxation rate enhancement in aqueous solution and in rat tissues. Radiology159:525-530, 1986
20.
Clanton JA: Oral contrast agents, in Partain CL , Price RR, Patton JA, et al (eds): Magnetic Resonance Imaging (edition 2, vol 1). Philadelphia, Saunders, 1988, pp 830-837
